Prostate Cancer - Results from #260

Current standards and practice changing studies in genitourinary (GU) cancers-a review of studies in localized/early GU cancers. March 14, 2022

Retzius-sparing Robot-assisted Radical Prostatectomy in High-risk Prostate Cancer Patients: Results from a Large Single-institution Series. March 14, 2022

ZERO – The End of Prostate Cancer Proud to Collaborate with Prostate Cancer Foundation for the Young Investigator Award to Eliminate Health Disparities March 11, 2022

First experiences and results after cryoablation of prostate cancer with histopathological evaluation and imaging-based follow-up. March 11, 2022

The Dilemma of Misclassification Rates in Senior Patients With Prostate Cancer, Who Were Treated With Robot-Assisted Radical Prostatectomy: Implications for Patient Counseling and Diagnostics. March 11, 2022

Analysis of BRCA Germline Mutations in Chinese Prostate Cancer Patients. March 11, 2022

Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. March 11, 2022

External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection. March 11, 2022

Immune mechanisms behind prostate cancer in men of African ancestry: A review. March 10, 2022

Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model. March 10, 2022

The role of radiotherapy in oligometastatic hormone-sensitive prostate cancer. March 10, 2022

Nuclear expression of pSTAT3Tyr705 and pSTAT3Ser727 in the stromal compartment of localized hormone-naïve prostate cancer. March 10, 2022

Current Opinion on the Use of Magnetic Resonance Imaging in Staging Prostate Cancer: A Narrative Review. March 10, 2022

Bayer Submits Applications in the U.S. and EU for Additional Indication of NUBEQA® (darolutamide) March 9, 2022

Multi-marker risk-based screening for prostate cancer. March 9, 2022

5-alpha reductase inhibitors and prostate cancer mortality among men with regular access to screening and health care. March 9, 2022

Quality of life after robotic-assisted and laparoscopic radical prostatectomy: Results of a multicenter randomized controlled trial (LAP-01). March 9, 2022

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database. March 9, 2022

Psychosocial Stress, Glucocorticoid Signaling, and Prostate Cancer Health Disparities in African American Men. March 9, 2022

The Future is Female: The Influence of Female Faculty and Resident Representation on Female Applicant Match Rate Amongst Urology Residency Programs Over 3 Years March 8, 2022

Page 14 of 1222

email news signup